GEC-targeted HO-1 expression reduces proteinuria in glomerular immune injury

被引:22
作者
Duann, Pu [1 ]
Lianos, Elias A. [1 ]
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, Div Nephrol, New Brunswick, NJ 08903 USA
关键词
glomerular epithelial cells; anti-GBM disease; heme oxygenase 1; glomerulonephritis; NITRIC-OXIDE SYNTHASE; REAL-TIME PCR; HEME OXYGENASE-1; BASEMENT-MEMBRANE; ACCURATE DETERMINATION; PERMEABILITY BARRIER; ZYGOSITY; GENE; MACROPHAGES; PRESERVES;
D O I
10.1152/ajprenal.00213.2009
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Duann P, Lianos EA. GEC-targeted HO-1 expression reduces proteinuria in glomerular immune injury. Am J Physiol Renal Physiol 297: F629-F638, 2009. First published July 8, 2009; doi:10.1152/ajprenal.00213.2009.-Induction of heme oxygenase (HO)-1 is a key defense mechanism against oxidative stress. Compared with tubules, glomeruli are refractory to HO-1 upregulation in response to injury. This can be a disadvantage as it may be associated with insufficient production of cytoprotective heme-degradation metabolites. We, therefore, explored whether 1) targeted HO-1 expression can be achieved in glomeruli without altering their physiological integrity and 2) this expression reduces proteinuria in immune injury induced by an anti-glomerular basement membrane (GBM) antibody (Ab). We employed a 4.125-kb fragment of a mouse nephrin promoter downstream to which a FLAG-tagged hHO-1 cDNA sequence was inserted and subsequently generated transgenic mice from the FVB/N parental strain. There was a 16-fold higher transgene expression in the kidney than nonspecific background (liver) while the transprotein immunolocalized in glomerular epithelial cells (GEC). There was no change in urinary protein excretion, indicating that GEC-targeted HO-1 expression had no effect on glomerular protein permeability. Urinary protein excretion in transgenic mice with anti-GBM Ab injury (days 3 and 6) was significantly lower compared with wild-type controls. There was no significant change in renal expression levels of profibrotic (TGF-beta 1) or anti-inflammatory (IL-10) cytokines in transgenic mice with anti-GBM Ab injury. These observations indicate that GEC-targeted HO-1 expression does not alter glomerular physiological integrity and reduces proteinuria in glomerular immune injury.
引用
收藏
页码:F629 / F638
页数:10
相关论文
共 35 条
[1]   EVIDENCE FOR SPLICING NEW BASEMENT-MEMBRANE INTO OLD DURING GLOMERULAR DEVELOPMENT IN NEWBORN RAT KIDNEYS [J].
ABRAHAMSON, DR ;
PERRY, EW .
JOURNAL OF CELL BIOLOGY, 1986, 103 (06) :2489-2498
[2]   TGF-beta in kidney fibrosis: A target for gene therapy [J].
Border, WA ;
Noble, NA .
KIDNEY INTERNATIONAL, 1997, 51 (05) :1388-1396
[3]   Use of real-time PCR for determining copy number and zygosity in transgenic plants [J].
Bubner, B ;
Baldwin, IT .
PLANT CELL REPORTS, 2004, 23 (05) :263-271
[4]   Loss of heparan sulfate glycosaminoglycan assembly in podocytes does not lead to proteinuria [J].
Chen, Shoujun ;
Wassenhove-McCarthy, Deborah J. ;
Yamaguchi, Yu ;
Holzman, Lawrence B. ;
van Kuppevelt, Toin H. ;
Jenniskens, Guido J. ;
Wijnhoven, Tessa J. ;
Woods, Ann C. ;
McCarthy, Kevin J. .
KIDNEY INTERNATIONAL, 2008, 74 (03) :289-299
[5]   Long-term effect of Heme oxygenase (HO)-1 induction in glomerular immune injury [J].
Datta, PK ;
Duann, P ;
Lianos, EA .
JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 2006, 147 (03) :150-155
[6]   Interactions between inducible nitric oxide synthase and heme oxygenase-1 in glomerulonephritis [J].
Datta, PK ;
Gross, EJ ;
Lianos, EA .
KIDNEY INTERNATIONAL, 2002, 61 (03) :847-850
[7]  
Datta PK, 1999, J AM SOC NEPHROL, V10, P2540
[8]   Differential nephron HO-1 expression following glomerular epithelial cell injury [J].
Datta, Prasun K. ;
Reddy, Sreenivas ;
Sharma, Mukut ;
Lianos, Elias A. .
NEPHRON EXPERIMENTAL NEPHROLOGY, 2006, 103 (04) :E131-E138
[9]   Superoxide dismutase mimetic preserves the glomerular capillary permeability barrier to protein [J].
Duann, P ;
Datta, PK ;
Pan, C ;
Blumberg, JB ;
Sharma, M ;
Lianos, EA .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 316 (03) :1249-1254
[10]  
Eremina V, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133788